Forum > ZEPOSIA (ozanimod)
(Abst.) Efficacy and safety of ozanimod in MS
(1/1)
agate:
"Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized Phase II study" by from PubMed, July 26, 2018:
https://www.ncbi.nlm.nih.gov/pubmed/30043658
agate:
Abstract of an article in The Lancet (September 3, 2019), "Safety and efficacy of ozanimod vs. interferon beta-1a in relapsing multiple sclerosis (RADIANCE): A multicentre, randomised, 24-month, phase 3 trial":
https://www.ncbi.nlm.nih.gov/pubmed/31492652
agate:
Abstract of an article in The Lancet (September 3, 2019) about a different trial (see previous post) involving ozanimod and interferon beta-1a--"Safety and efficacy of ozanimod vs. interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): A multicentre, randomised, minimum 12-month, phase 3 trial":
https://www.ncbi.nlm.nih.gov/pubmed/31492651
Navigation
[0] Message Index
Go to full version